Copyright
©The Author(s) 2015.
World J Stem Cells. Oct 26, 2015; 7(9): 1185-1201
Published online Oct 26, 2015. doi: 10.4252/wjsc.v7.i9.1185
Published online Oct 26, 2015. doi: 10.4252/wjsc.v7.i9.1185
Cancer type | Surfaceantigens | Ref. |
Leukemia | CD34+CD38-CD47+CCL-1+CD96+ TIM3+CD32+CD25+ | [11,20-24] |
Brain | CD133+ | [12] |
Head and neck | CD44+CD24+ | [14] |
Breast | ESA+CD44+CD24- | [13,16] |
Pancreatic | ESA+CD44+CD24+ | [13,40] |
Lung | CD133+CD44+ | [15] |
Liver | ESA+CD133+CD90+CD44+CD24+ | [17] |
Gastric | CD44+ | [18,38] |
Colorectal | ESA+CD133+CD166+CD44+CD24+ | [19,26] |
- Citation: Dragu DL, Necula LG, Bleotu C, Diaconu CC, Chivu-Economescu M. Therapies targeting cancer stem cells: Current trends and future challenges. World J Stem Cells 2015; 7(9): 1185-1201
- URL: https://www.wjgnet.com/1948-0210/full/v7/i9/1185.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v7.i9.1185